Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
One of the key challenges of cancer biology is to catalogue and understand the somatic genomic alterations leading to cancer. Although alternative definitions and search methods have been developed to identify cancer driver genes and mutations, analyses of thousands of cancer genomes return a remarkably similar catalogue of around 300 genes that are mutated in at least one cancer type. Yet, many features of these genes and their role in cancer remain unclear, first and foremost when a somatic mutation is truly oncogenic. In this review, we first summarize some of the recent efforts in completing the catalogue of cancer driver genes. Then, we give an overview of different aspects that influence the oncogenicity of somatic mutations in the core cancer driver genes, including their interactions with the germline genome, other cancer driver mutations, the immune system, or their potential role in healthy tissues. In the coming years, this research holds promise to illuminate how, when, and why cancer driver genes and mutations are really drivers, and thereby move personalized cancer medicine and targeted therapies forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These driver mutations play a crucial role in the development and progression of cancer by promoting malignant transformation in cells [27].”
From The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies (2025) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationMolecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Ioannidis, N. M., Rothstein, J. H., Pejaver, V., Middha, S., McDonnell, S. K., Baheti, S., Musolf, A., Li, Q., Holzinger, E., Karyadi, D., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.016 · Cited by 2,908
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256
Self-citationUnresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0060-1 · Cited by 1,597
Universal Patterns of Selection in Cancer and Somatic Tissues
Martincorena, I., Raine, K. M., Gerstung, M., Dawson, K. J., Haase, K., Van Loo, P., Davies, H., Stratton, M. R., & Campbell, P. J. (2017) · Cell · doi:10.1016/j.cell.2017.09.042 · Cited by 1,523
Spranger, S., Dai, D., Horton, B., & Gajewski, T. F. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.003 · Cited by 1,441
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
McGranahan, N., Rosenthal, R., Hiley, C. T., Rowan, A. J., Watkins, T. B. K., Wilson, G. A., Birkbak, N. J., Veeriah, S., Van Loo, P., Herrero, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.001 · Cited by 1,298
Somatic mutant clones colonize the human esophagus with age
Martincorena, I., Fowler, J. C., Wabik, A., Lawson, A. R. J., Abascal, F., Hall, M. W. J., Cagan, A., Murai, K., Mahbubani, K., Stratton, M. R., et al. (2018) · Science · doi:10.1126/science.aau3879 · Cited by 1,113
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
Blount, Z. D., Borland, C. Z., & Lenski, R. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803151105 · Cited by 840
Understanding multicellular function and disease with human tissue-specific networks
Greene, C. S., Krishnan, A., Wong, A. K., Ricciotti, E., Zelaya, R. A., Himmelstein, D. S., Zhang, R., Hartmann, B. M., Zaslavsky, E., Sealfon, S. C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3259 · Cited by 832
Chang, M. T., Asthana, S., Gao, S. P., Lee, B. H., Chapman, J. S., Kandoth, C., Gao, J., Socci, N. D., Solit, D. B., Olshen, A. B., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3391 · Cited by 808
The landscape of somatic mutation in normal colorectal epithelial cells
Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R. J., Sanders, M. A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1672-7 · Cited by 747
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Zhang, Y., Kwok-Shing Ng, P., Kucherlapati, M., Chen, F., Liu, Y., Tsang, Y. H., de Velasco, G., Jeong, K. J., Akbani, R., Hadjipanayis, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.013 · Cited by 626
KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer
Liao, W., Overman, M. J., Boutin, A. T., Shang, X., Zhao, D., Dey, P., Li, J., Wang, G., Lan, Z., Li, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.008 · Cited by 617
Mutational processes shape the landscape of TP53 mutations in human cancer
Giacomelli, A. O., Yang, X., Lintner, R. E., McFarland, J. M., Duby, M., Kim, J., Howard, T. P., Takeda, D. Y., Ly, S. H., Kim, E., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0204-y · Cited by 556
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
Yizhak, K., Aguet, F., Kim, J., Hess, J. M., Kübler, K., Grimsby, J., Frazer, R., Zhang, H., Haradhvala, N. J., Rosebrock, D., et al. (2019) · Science · doi:10.1126/science.aaw0726 · Cited by 500
The mutational landscape of normal human endometrial epithelium
Moore, L., Leongamornlert, D., Coorens, T. H. H., Sanders, M. A., Ellis, P., Dentro, S. C., Dawson, K. J., Butler, T., Rahbari, R., Mitchell, T. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2214-z · Cited by 499
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Ding, L., Bailey, M. H., Porta-Pardo, E., Thorsson, V., Colaprico, A., Bertrand, D., Gibbs, D. L., Weerasinghe, A., Huang, K.-L., Tokheim, C., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.033 · Cited by 399
Self-citationBurke, J. E., Perisic, O., Masson, G. R., Vadas, O., & Williams, R. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205508109 · Cited by 300
Kotler, E., Shani, O., Goldfeld, G., Lotan-Pompan, M., Tarcic, O., Gershoni, A., Hopf, T. A., Marks, D. S., Oren, M., & Segal, E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.012 · Cited by 285
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
Zhu, M., Lu, T., Jia, Y., Luo, X., Gopal, P., Li, L., Odewole, M., Renteria, V., Singal, A. G., Jang, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.026 · Cited by 250
Mighell, T. L., Evans-Dutson, S., & O’Roak, B. J. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.018 · Cited by 204
Deconstruction of the Ras switching cycle through saturation mutagenesis
Bandaru, P., Shah, N. H., Bhattacharyya, M., Barton, J. P., Kondo, Y., Cofsky, J. C., Gee, C. L., Chakraborty, A. K., Kortemme, T., Ranganathan, R., et al. (2017) · eLife · doi:10.7554/elife.27810 · Cited by 117
Research works printed but not linked: 65
- 10.1038/ng.2764 · DOI · Paper page
- 10.1038/srep02650 · DOI · Paper page
- 10.1038/nmeth.2642 · DOI · Paper page
- 10.1126/science.1235122 · DOI · Paper page
- Chakravarty D, 2017, OncoKB: a precision oncology knowledge base, JCO Precis Oncol, 2017, 1, 10.1200/PO.17.00011 · DOI · Paper page
- 10.1534/genetics.115.175802 · DOI · Paper page
- 10.1016/j.celrep.2016.09.061 · DOI · Paper page
- 10.1016/j.ccell.2016.06.022 · DOI · Paper page
- 10.1016/j.ccell.2018.01.021 · DOI · Paper page
- 10.1016/j.cell.2017.01.018 · DOI · Paper page
- 10.1038/nature19057 · DOI · Paper page
- 10.1016/j.cell.2012.12.034 · DOI · Paper page
- 10.1016/j.tig.2019.04.005 · DOI
- 10.1038/ng.341 · DOI · Paper page
- 10.1158/0008-5472.CAN-10-2689 · DOI
- 10.1158/2159-8290.CD-16-1045 · DOI · Paper page
- 10.1186/gb-2008-9-s1-s4 · DOI · Paper page
- 10.1093/bioinformatics/btq615 · DOI · Paper page
- 10.1016/j.ajhg.2008.02.013 · DOI · Paper page
- 10.1371/journal.pcbi.1000641 · DOI · Paper page
- 10.1038/ng.3168 · DOI · Paper page
- 10.1038/nmeth.2651 · DOI · Paper page
- 10.1186/gb-2012-13-12-r124 · DOI · Paper page
- 10.1186/s13073-014-0056-8 · doi:10.1186/s13073-014-0056-8 · Paper page
- 10.1371/journal.pcbi.1003460 · DOI · Paper page
- 10.1186/s13059-016-0989-x · DOI · Paper page
- 10.1093/neuonc/noz009 · DOI
- 10.1016/j.ccell.2016.04.001 · DOI · Paper page
- 10.1158/0008-5472.CAN-18-0362 · DOI · Paper page
- 10.1038/ng.3726 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-0465 · DOI
- 10.1016/j.ccell.2018.08.019 · DOI · Paper page
- 10.1016/0092-8674(90)90186-I · DOI · Paper page
- 10.1016/j.cell.2018.03.043 · DOI · Paper page
- 10.1056/NEJMoa1412098 · DOI · Paper page
- 10.1158/2159-8290.CD-17-0343 · DOI · Paper page
- 10.1016/j.cell.2017.09.050 · DOI · Paper page
- 10.1016/j.cell.2018.08.048 · DOI · Paper page
- 10.1056/NEJMoa1002011 · DOI · Paper page
- 10.1038/s41586-019-1382-1 · DOI · Paper page
- 10.1126/science.aaw3472 · DOI · Paper page
- 10.1038/nrc.2017.5 · DOI · Paper page
- 10.1016/j.cell.2014.05.027 · DOI
- Olafsson S, 2019, The mutational profile and clonal landscape of the inflammatory bowel disease affected colon, bioRxiv
- 10.1186/s13059-019-1919-5 · DOI · Paper page
- 10.1101/cshperspect.a026542 · DOI
- Sabarinathan R, 2017, The whole‐genome panorama of cancer drivers, bioRxiv
- 10.1038/s41523-017-0051-5 · DOI
- 10.1093/nar/gkg509 · DOI · Paper page
- 10.1038/nmeth0410-248 · DOI · Paper page
- 10.1093/nar/gkr407 · DOI · Paper page
- 10.1186/gm390 · DOI · Paper page
- 10.1038/ng.2892 · DOI · Paper page
- 10.1038/ng.3703 · DOI · Paper page
- 10.1186/1471-2164-14-S3-S3 · DOI · Paper page
- 10.1093/bioinformatics/btt182 · DOI · Paper page
- 10.1371/journal.pone.0077945 · DOI · Paper page
- 10.1093/bioinformatics/btr357 · DOI · Paper page
- 10.1038/ng.3658 · DOI
- 10.1158/0008-5472.CAN-15-3190 · DOI · Paper page
- 10.1038/ng.3586 · DOI · Paper page
- 10.1186/s13073-016-0393-x · DOI · Paper page
- 10.1371/journal.pcbi.1004518 · DOI · Paper page
- 10.1038/s41598-018-36401-4 · DOI
- 10.1016/j.cels.2019.05.005 · DOI · Paper page
Cited by
Computed cancer interactome explains the effects of somatic mutations in cancers
Zhang, J., Pei, J., Durham, J., Bos, T., & Cong, Q. (2022) · Protein Science · doi:10.1002/pro.4479 · Cited by 31
“Cancer-causing genetic alterations lead to activation of oncogenes or deactivation of tumor suppressor genes (TSGs), which can occur through structural changes of chromosomes, fusion of individual genes, as well as germline or somatic mutations at individual nucleotide positions.(20) Somatic mutations in cancer have b…”
BackgroundMahmoud, A. A., Raih, M. F., Sage, E. E., Ali, Q. M., Suliman, O. H., Ibrahim, S. A. E., Mohamed, O., Abdelrazeg, S., & Mohamed, S. B. (2025) · PLOS One · doi:10.1371/journal.pone.0307859 · Cited by 4
Metadata
- Authors
- Porta‐Pardo, E., Valencia, A., & Godzik, A.
- Affiliations
- Barcelona Supercomputing Center (BSC) Barcelona Spain
- Division of Biomedical Sciences University of California Riverside School of Medicine Riverside CA USA
- ORCID
- Godzik, Adam
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2020-04-28
- Volume
- 594
- Issue
- 24
- Pages
- 4233-4246
- ISSN
- 0014-5793
- 1873-3468
- Cited by
- 54
- References
- 31
- Language
- en
- Funders
- National Institute of General Medical Sciences (GM118187)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.